Recombinant Human GDF-9 (Catalog # 8266-G9) induces Mv1Lu mink lung epithelial cell death. The ED50 for this effect is 50-250 ng/mL.
1 μg/lane of Recombinant Human GDF-9 was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining, showing single bands at 20 kDa and 26 kDa, respectively.
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Bioactivity
Theoretical MW
16 kDa (monomer). Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
20-22 kDa, reducing conditions
Publications
Read Publications using 8266-G9 in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in HCl with BSA as a carrier protein.
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Reconstitution Instructions
Reconstitute at 100 μg/mL in strerile 4 mM HCl.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human GDF-9 Protein
GDF9
GDF-9
growth differentiation factor 9
growth/differentiation factor 9
Background
Growth Differentiation Factor-9 (GDF-9) is an oocyte secreted paracrine factor in the TGF-beta superfamily (1, 2). It is synthesized as a prepropeptide and is subsequently processed by proteases into the mature protein (1, 2). Mature human GDF-9 has a predicted molecular weight of 16 kDa and shares 89.6% and 91.9% amino acid sequence identity with the mouse and rat orthologs, respectively. Despite the high homology, mouse GDF-9 is secreted in an active form, while human GDF-9 is latent. A single mutation Gly391Arg increases the affinity between human GDF-9 and its signaling receptors and make it more active (3). It forms both non-covalent homodimers and heterodimers with BMP-15, which is coordinately expressed with GDF-9 in the oocyte. (2, 4, 5). GDF-9 signals through TGF-beta RI/ALK-5 and BMPR-II, while the GDF-9:BMP-15 heterodimer is believed to signal through BMPR-II, ALK 4/5/7, and BMPR-IB/ALK-6 (5-8). SMAD2 and SMAD3 are phosphorylated following activation of receptor complexes by GDF-9 (5, 6). GDF-9 functions as a paracrine factor in the development of primary follicles in the ovary. It is critical for the growth of granulosa and theca cells and for the differentiation and maturation of the oocyte (5, 9-11). GDF-9 is thought to act synergistically with BMP-15 to control development of the oocyte-cumulus cell complex (4-6). In humans, GDF-9:BMP-15 heterodimers have been shown to be more potent regulators of granulosa cell functions compared to GDF-9 homodimers (6). Aberrant GDF-9 expression and activation is associated with a multitude of common human ovarian disorders including premature ovarian failure and polycystic ovary syndrome (10, 12-14). In breast and bladder cancers, GDF-9 is believed to function as a tumor suppressor because its expression levels are inversely correlated with the aggressiveness of the cancer (15, 16). In prostate cancer, however, GDF-9 may enhance tumor progression by promoting tumor cell growth and epithelial-to-mesenchymal transition (17, 18).
McGrath, S. A. et al. (1995) Mol. Endocrinol. 9:131.
Aaltonen, J. et al. (1999) J. Clin. Endocrinol. Metab. 84:2744.
Simpson, C.M. et al. (2012) 153:1301.
Liao, W.X. et al. (2003) J. Biol. Chem. 278:3713.
Gilchrist, R.B. et al. (2008) Hum. Reprod. Update 14:159.
Peng, J. et al. (2013) Proc. Natl. Acad. Sci. USA 110:E776.
Vitt, U.A. et al. (2002) Biol. Reprod. 67:473.
Mazerbourg, S. et al. (2004) Mol. Endocrinol. 18:653.
Hreinsson, J.G. et al. (2002) J. Clin. Endocrinol. Metab. 87:316.
Otsuka, F. et al. (2011) Mol. Reprod. Dev. 78:9.
Dong, J. et al. (1996) Nature 383:531.
Zhao, S.Y. et al. (2010) Fertil. Steril. 94:261.
Wei, L.N. et al. (2011) Fertil. Steril. 96:464.
Simpson, C.M. et al. (2014) J. Clin. Endocrinol. Metab. [Epub ahead of print].
Hanavadi, S. et al. (2007) Ann. Surg. Oncol. 14:2159.
Du, P. et al. (2012) Int. J. Mol. Med. 29:428.
Bokobza, S.M. et al. (2010) J. Cell. Physiol. 225:529.
Bokobza, S.M. et al. (2011) Mol. Cell. Biochem. 349:33.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human GDF-9 Protein and receive a gift card or discount.